secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001140361-25-026946
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharmaceuticals cuts workforce 30%, extends cash runway into Q2 2027
---------------------------------------------------------------------------

- Reduction in workforce of ~30%; expected to cut 12-month operating expenses by ~25%.
- Estimated $3.5M in restructuring charges in H2 2025; severance for ~80 employees.
- Board approved Plan on June 18, 2025; RIF began July 23, to be completed by August 8, 2025.
- Restructuring aims to maximize near-term value and extend operational runway into Q2 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/0001140361-25-026946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/ef20052517_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-026946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer